COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,254 Articles (22,733 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 1159: Articles 11581-11590  | Next

How many lives do COVID vaccines save? Evidence from Israel.
Arbel, R., Moore, C. M., Sergienko, R., Pliskin, J.
10.1101/2021.10.27.21265591 — Posted: 2021-10-28
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
Crowley, A. R., Natarajan, H., Hederman, A. P., Bobak, C. A., Weiner, J. A., Wieland-Alter, W. F., Lee, J., Bloch, E. M., Tobian, A. A., Redd, A., Blankson, J. N., Wolf, D., Goetghebuer, T., Marchant, A., Connor, R. I., Wright, P. F., Ackerman, M. E.
10.1101/2021.10.27.21265574 — Posted: 2021-10-28
Implementation and extended evaluation of the Euroimmun Anti-SARS-CoV-2 IgG assay and its contribution to the United Kingdom's COVID-19 public health response
Otter, A. D., Bown, A., D'Arcangelo, S., Bailey, D., Semper, A., Hewson, J., Catton, M., Perumal, P., Sweed, A., Jones, J., Harvala, H., Lamikanra, A., Zambon, M., Andrews, N., Whitaker, H., Linley, E., Mentzer, A. J., Skelly, D., Knight, J., Klenerman, P., PHE Porton Euroimmun testing group, , Amirthalingam, G., Taylor, S., Rowe, C., Vipond, R., Brooks, T.
10.1101/2021.10.26.21265497 — Posted: 2021-10-28
Impact of non-pharmacological interventions on COVID-19 boosting vaccine prioritization and vaccine-induced herd immunity: a population-stratified modelling study
Li, Z., Wang, J., Yang, B., Li, W., Xu, J., Wang, T.
10.1101/2021.10.27.21265522 — Posted: 2021-10-28
COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication from the COVID and Cognition Study.
Guo, P., Benito Ballesteros, A., Yeung, S. P., Liu, R., Saha, A., Curtis, L., Kaser, M., Haggard, M. P., Cheke, L. G.
10.1101/2021.10.27.21265563 — Posted: 2021-10-28 Discussion: Onsite
Detection of SARS-CoV-2 RNA Throughout Wastewater Treatment Plants and A Modeling Approach to Understand COVID-19 Infection Dynamics in Winnipeg, Canada
Yanac, K., Adegoke, A., Wang, L., Yuan, Q., Uyaguari, M.
10.1101/2021.10.26.21265146 — Posted: 2021-10-28
Regional probabilistic situational awareness and forecasting of COVID-19
Engebretsen, S., Palomares, A. D.-L., Rø, G. Øvind I., Kristoffersen, A. B., Lindstrøm, J. C., Engø-Monsen, K., Chan, L. Y. H., Dale, Ørjan, Midtbø, J. E., Lindalen-Stenerud, K., Di Ruscio, F., White, R. A., Frigessi, A., de Blasio, B. F.
10.1101/2021.10.25.21265166 — Posted: 2021-10-27
Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe
Rosenblum, H. G., Gee, J. M., Liu, R., Marquez, P. L., Zheng, B., Strid, P., Abara, W. E., McNeil, M. M., Myers, T. R., Hause, A. M., Su, J. R., Baer, B., Menschik, D., Markowitz, L. E., Shimabukuro, T. T., Shay, D. K.
10.1101/2021.10.26.21265261 — Posted: 2021-10-27 Discussion: Onsite
The Persistence of Neutralising Antibodies up to 11 months after SARS-CoV-2 Infection in the Southern Region of New Zealand
McGregor, R., Craigie, A. K., Jack, S., Upton, A., Moreland, N. J., Ussher, J.
10.1101/2021.10.26.21265501 — Posted: 2021-10-27
Dampening of the respiratory cytokine storm is promoted by inhaled budesonide in patients with early COVID-19
Baker, J. R., Mahdi, M., Nicolau, D. V., Ramakrishnan, S., Barnes, P. J., Simpson, J. L., Cass, S., Russell, R. E. K., Donnelly, L. E., Bafadhel, M.
10.1101/2021.10.26.21265512 — Posted: 2021-10-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).